About Justin Kao
Form D filings for Inflammatix in 2021 list Justin Kao as director.
Justin Kao first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Justin Kao in the role, so the role may have started earlier or lasted longer.
Inflammatix, Inc.
Director
2021 · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.
Key Colleagues at Startups
The people Justin Kao works with at each company, as listed on that company's latest Form D.
Inflammatix, Inc. · Form D, Mar 24, 2021
MR
Michael Rubin
Director
KB
Kenneth Bahk
Director

Timothy Sweeney
Co-Founder and CEO, director

Steven Tablak
Former Chairman and CEO, GeneWeave

David Persing
EVP/Chief Medical Officer, Cepheid and director